Zynex, Inc. (ZYXI)
NASDAQ: ZYXI · Real-Time Price · USD
1.680
+0.020 (1.20%)
At close: Aug 27, 2025, 4:00 PM
1.650
-0.030 (-1.79%)
After-hours: Aug 27, 2025, 7:38 PM EDT
Zynex Market Cap
Zynex has a market cap or net worth of $50.90 million as of August 27, 2025. Its market cap has decreased by -78.28% in one year.
Market Cap
50.90M
Enterprise Value
105.82M
1-Year Change
-78.28%
Ranking
Category
Stock Price
$1.68
Market Cap Chart
Since February 12, 2019, Zynex's market cap has decreased from $154.40M to $50.90M, a decrease of -67.03%. That is a compound annual growth rate of -15.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2025 | 50.90M | -80.05% |
| Dec 31, 2024 | 255.10M | -30.90% |
| Dec 29, 2023 | 369.20M | -29.14% |
| Dec 30, 2022 | 521.00M | 50.23% |
| Dec 31, 2021 | 346.80M | -25.83% |
| Dec 31, 2020 | 467.60M | 81.45% |
| Dec 31, 2019 | 257.70M | 66.90% |
| Feb 12, 2019 | 154.40M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 624.22B |
| Johnson & Johnson | 429.67B |
| AbbVie | 366.65B |
| UnitedHealth Group | 276.10B |
| Novo Nordisk | 255.49B |
| AstraZeneca | 251.25B |
| Novartis AG | 244.09B |
| Abbott Laboratories | 229.51B |